Skip to main content
TipRanks
Go Ultimate75% OFF

Archean Chemical Industries Ltd. (ACI) AI Stock Analysis

1 Followers
IN:ACI

Archean Chemical Industries Ltd.

(NSE:ACI)

Select Model
Rating:46Neutral
Price Target:INR 435.00â–¼(-0.26% Downside)
Action:reiterated
Date:11/18/26

The overall score is low, driven primarily by a significant deterioration in financial performance, particularly the negative free cash flow and declining profitability, which raises concerns about the company's operational health. This is compounded by a persistently bearish technical trend and a stretched valuation that does not reflect the current earnings trajectory.

Positive Factors
Bromine-based product platformACI serves multiple industrial applications through bromine, bromine-derived specialty chemicals, and industrial salt. This product platform provides more than one revenue stream and keeps the company connected to downstream chemical demand across several customer uses over the medium term.
Negative Factors
Three-year revenue declineRevenue contraction across three consecutive years indicates sustained pressure on demand, realized pricing, sales volumes, or product mix rather than a single-period fluctuation. If the trend persists, it can reduce scale benefits and make recovery in earnings and cash generation more difficult.

Archean Chemical Industries Ltd. (ACI) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%IN:ACI-18.46%INDA-5.07%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 53.86B
Dividend Yield
0.57%
Average Volume (3M)
112.21K
Price to Earnings (P/E)
53.7
Beta (1Y)
0.33
Revenue Growth
5.99%
EPS Growth
-41.58%
Country
India
Employees
257
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Archean Chemical Industries Ltd. Business Overview & Revenue Model

Company Description

Archean Chemical Industries Limited operates as a manufacturer and global distributor of specialized chemicals extracted from marine sources, serving markets both within India and worldwide. Its product portfolio prominently features bromine, an esse...

How the Company Makes Money

ACI makes money primarily by manufacturing and selling (1) bromine, (2) bromine derivatives (specialty chemicals made using bromine as a key input), and (3) industrial salt. Revenue is generated through supply contracts and purchase orders with indus...

Archean Chemical Industries Ltd. Financial Statement Overview

Summary

Financial performance is mixed. The balance sheet is strong with low leverage (D/E 0.24) and a solid equity base, but this is offset by a sharp decline in revenue, compressed margins, and critically weak cash flows that have turned negative. The overall financial health is under pressure from deteriorating operations.

Income Statement

45Neutral

Balance Sheet

75Positive

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue11.80B10.81B10.41B13.30B14.40B11.30B
Gross Profit9.61B7.20B10.49B12.16B14.37B8.50B
EBITDA2.52B2.47B3.11B5.06B6.77B4.79B
Net Income997.96M1.07B1.62B3.19B3.83B1.88B
Balance Sheet
Total Assets28.27B26.65B23.93B20.56B17.55B15.31B
Cash, Cash Equivalents and Short-Term Investments703.85M610.77M2.55B3.95B2.31B695.11M
Total Debt5.51B4.66B2.35B978.23M693.85M9.00B
Total Liabilities8.67B7.32B5.29B3.54B3.24B12.69B
Stockholders Equity19.63B19.34B18.64B17.02B14.31B2.62B
Cash Flow
Free Cash Flow0-2.50B-873.38M1.71B3.96B2.18B
Operating Cash Flow01.32B1.76B3.79B4.96B3.15B
Investing Cash Flow0-2.96B-2.46B-3.07B-2.90B-1.10B
Financing Cash Flow01.64B649.80M-325.69M-2.12B-2.24B

Archean Chemical Industries Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price436.15

Price Trends

50DMA463.11Negative
100DMA494.01Negative
200DMA530.81Negative

Market Momentum

MACD-9.08Negative
RSI43.69Neutral
STOCH50.86Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACI, the sentiment is Negative. The current price of 436.15 is below the 20-day moving average (MA) of 444.78, below the 50-day MA of 463.11, and below the 200-day MA of 530.81, indicating a bearish trend. The MACD of -9.08 indicates Negative momentum. The RSI at 43.69 is Neutral, neither overbought nor oversold. The STOCH value of 50.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ACI.

Archean Chemical Industries Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

IN:ACI against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:GHCLIN:GHCL76OutperformINR 41.83B7.79―2.64%1.69%-1.63%
IN:GNFCIN:GNFC71OutperformINR 68.77B6.53―4.48%22.49%65.41%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
IN:DEEPAKNTRIN:DEEPAKNTR56NeutralINR 216.86B20.07―0.48%25.13%99.89%
IN:GUJALKALIIN:GUJALKALI54NeutralINR 43.40B32.07―3.06%11.16%88398.04%
IN:TATACHEMIN:TATACHEM47NeutralINR 165.45B-6.84―1.73%4.93%-1174.55%
IN:ACIIN:ACI46NeutralINR 53.85B53.69―0.57%5.99%-41.58%

* Basic Materials Sector Average

Performance Comparison

-20%0%20%40%IN:ACIIN:DEEPAKNTRIN:GHCLIN:GNFCIN:GUJALKALIIN:TATACHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:ACI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:ACIArchean Chemical Industries Ltd.436.15-102.01-18.96%
IN:DEEPAKNTRDeepak Nitrite Limited1561.25-122.76-7.29%
IN:GHCLGhcl Limited454.00-126.46-21.79%
IN:GNFCGujarat Narmada Valley Fertilizers & Chemicals Ltd.468.00-7.18-1.51%
IN:GUJALKALIGujarat Alkalies & Chemicals Ltd.579.1047.778.99%
IN:TATACHEMTata Chemicals Limited634.70-162.95-20.43%

Archean Chemical Industries Ltd. Corporate Events

Archean Chemical Releases Q2 and H1 FY27 Investor Presentation

Nov 2, 2026

Archean Chemical Industries Limited announced the release of an investor presentation for its earnings call covering the quarter and half year ended September 30, 2026. Submitted to the stock exchanges under applicable SEBI disclosure requirements, t...

Archean Chemical’s Long-Term Bank Facilities See Rating Downgrade as Borrowings Rise

Oct 22, 2026

Archean Chemical Industries Ltd. has disclosed that CRISIL has downgraded its rating on the company’s long-term bank facilities, even as the total rated amount has been significantly increased. The long-term facilities have risen from Rs.265 crore to...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026